VERBIO Vereinigte Bioenergie

Verbio's shares fell about 5.7 percent to roughly €30 after the detailed annual figures and outlook disappointed investors. CEO Claus Sauter is aiming for a further significant reduction in net debt and an EBITDA of €210–€250 million for the fiscal year to June 2027. The midpoint of the range is roughly seven percent below market expectations, even though the final quarter 2025/26 improved profitability thanks to higher sales volumes and increased utilization. The stock again bounced off a technical resistance level near the 100-day line. » Mere på finanzen.net

Verbio raised revenue in fiscal year 2025/26 by 18.5% to €1.87 billion; EBITDA climbed from €14.2 million to almost €194 million. Operating cash flow improved to €164.6 million, enabling debt reduction and boosting the equity ratio to 59.7%. For 2026/27 management is targeting EBITDA of €210–250 million, while analysts on average expect €241 million. » Mere på deraktionaer.de

VERBIO Vereinigte BioEnergie will present results for the quarter ended 30.06.2026 on 24.09.2026. One analyst expects earnings of 0.87 EUR per share after -1.53 EUR in the year‑ago quarter and revenue of around 564.0 Mio. EUR (+30.14% versus 433.4 Mio. EUR). For the fiscal year just ended, on average four analysts forecast earnings per share of 0.899 EUR (previously -2.170 EUR) with revenue of about 1.78 Mrd. EUR (prior year 1.58 Mrd. EUR). » Mere på finanzen.net